Patent ID: 7037667
Filing Date: 2006-05-02
Classification: C12Q,G01N

Abstract:
1. A method of identifying evidence of a neoplasm in a biological sample comprising: (a) examining a level of expression of 20P1F12/TMPRSS2 gene, which encodes the protein of SEQ. ID. NO:2 (FIG. (b) comparing the level of said 20P1F12/TMPRSS2 gene expression in the test biological sample to a level of said 20P1F12/TMPRSS2 gene expression found in a comparable normal biological sample, wherein an enhanced level of 20P1G12/TMPRSS2 gene expression in the test biological sample relative to the normal biological sample is evidence of a neoplasm, and wherein the neoplasm is a prostate cancer.